secwatch.observer — SEC 8-K summary
======================================

Issuer:     USBC, Inc. (USBC)
CIK:        0001074828
Form:       8-K
Filed at:   2022-05-31T23:59:59+00:00
Accession:  0001161697-22-000276
Event type: leadership
Sentiment:  positive
Materiality: 0.60
Item codes: 5.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Know Labs appoints CFO Peter Conley and CPO Steven Kent to lead toward FDA clearance
--------------------------------------------------------------------------------

- Peter Conley appointed CFO and SVP Intellectual Property, with 34 years finance and IP experience.
- Steven Kent appointed Chief Product Officer, responsible for product development and clinical testing.
- Company progresses toward FDA clearance for non-invasive glucose monitor; executive team expanded.
- Leo Trautwein remains CMO; Masanori King Takee as SVP Software Engineering.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1074828/000116169722000276/0001161697-22-000276-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1074828/000116169722000276/form_8-k.htm
  HTML page:      https://secwatch.observer/filing/0001161697-22-000276

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer